FAQs
Q1. How does Pimecrolimus in Pacroma 1% Cream differ from a steroid cream for eczema?
A1. Pimecrolimus is a calcineurin inhibitor, not a corticosteroid. It selectively blocks calcineurin in T-lymphocytes, preventing release of inflammatory cytokines (IL-2, IL-4, TNF-α, IFN-γ) that drive eczema flares — without affecting collagen synthesis or skin thickness. This means Pacroma 1% Cream carries none of the skin-thinning, telangiectasia, or adrenal suppression risks associated with long-term steroid use, making it preferable for sensitive areas requiring extended management.
Q2. Which body sites is Pacroma 1% Cream most suitable for?
A2. Pacroma is designed specifically for sensitive sites where corticosteroids must be avoided or used sparingly — the face (especially eyelids and perioral skin), skin folds, neck, axillae, and in children, the diaper area. Its steroid-sparing profile makes it the preferred option for long-term intermittent use to control recurring eczema flares on these areas under dermatologist guidance.
Q3. Can Pacroma 1% Cream be used for children, and from what age?
A3. Pacroma 1% Cream (Pimecrolimus 1%) is prescribed for children aged 2 years and above under medical supervision. It is not recommended for children under 2 years. Parents should apply exactly as directed by the prescribing dermatologist and avoid using on larger body areas than specified.
Q4. Is Pacroma a one-time treatment or is it used long-term?
A4. Pacroma 1% Cream is typically used intermittently — applied twice daily at the first signs of a flare until the skin clears, then discontinued. For patients with frequent recurrences, dermatologists may prescribe proactive intermittent therapy: applying twice weekly on previously affected areas to prevent new flares. Ongoing prescription monitoring is important for long-term management.
Q5. Are there sun exposure precautions while using Pacroma?
A5. While using Pacroma 1% Cream, minimise prolonged UV exposure and apply broad-spectrum SPF on treated areas as a precaution — particularly relevant across India's high-UV environment. Pacroma should always be used as prescribed by a registered dermatologist and is a Schedule H prescription-only product.